FCX vs ISPC · P/E 38, rev $25.45B vs rev $9.3M
Freeport-McMoran Copper & Gold Inc (FCX) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the FCX and ISPC stock pages for the full models.
Not investment advice.